Reshape Lifesciences Inc.
13F holders, Q4 2024 (December 31)10holders +1
1new positions
1sold out
$4.46avg. 13F price*
At the end of Q4 2024, 10 institutions reported holding Reshape Lifesciences Inc. in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 1 sold out. The largest holders were UBS Group AG ($79K), Tower Research Capital LLC (TRC) ($4K) and BlackRock, Inc. ($3K).
- Company
- Reshape Lifesciences Inc.
- CUSIP
- 76090R309
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4 |
| Exits | 1 | $6 |
All 13F filers, Q3 2024 → Q4 2024: 17,849 shares bought and 1 shares sold, net +17,848 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| UBS Group AG | 0.00% | Add +1766400.0% | 17,665 | $79K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +27.4% | 847 | $4K |
| BlackRock, Inc. | 0.00% | No change | 588 | $3K |
| Bank of America Corp. | 0.00% | Add +50.0% | 6 | $27 |
| Danske Bank A/S | 0.00% | No change | 2 | $9 |
| Group One Trading LLC | 0.00% | No change | 2 | $9 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 1 | $5 |
| Morgan Stanley | 0.00% | No change | 1 | $4 |
| Osaic Holdings, Inc. | 0.00% | New | 1 | $4 |
| SBI Securities Co., Ltd. | 0.00% | — | 1 | $4 |
"% of holder's portfolio" is RESHAPE LIFESCIENCES INC's weight in each manager's 13F, not the share of Reshape Lifesciences Inc. the manager owns.